Cardiometabolic Risk

A new comprehensive review examined the effects of regular consumption of sugar-sweetened beverages on the risk of diabetes, cardiovascular disease, and stroke.

The FDA has approved 2 new drugs for the improvement of blood glucose control in patients with type 1 and type 2 diabetes mellitus.

A recent study examined the effects of fidgeting on all-cause mortality risk in individuals who sit for more than 7 hours a day.

A recent report from a non-profit, independant research group addresses the cost-effectiveness and budgetary impact of treatment with PCSK9 inhibitors.

A recent study compared the effects of long-term high and low dietary salt consumption on the risk of developing hypertension.

Researchers collected data from the National Health and Nutrition Examination Survey to estimate the prevalence of obesity and overweight in the United States.

In a new study, researchers examined the effects of exposure to moderate levels of light on body mass index and body fat.

An FDA advisory committee has voted to recommend approval of a new drug for the long-term treatment of patients with hypercholesterolemia and dyslipidemia.

Researchers examined the potential of newly identified chemical markers for adiposity from the urine of over 2000 individuals.